EC
CERE

EcoR1 Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

EcoR1 Capital’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,646,260
Closed -$43.5M – 87
2022
Q2 		$43.5M Hold
1,646,260
– – 1.5% 21
2022
Q1 		$57.6M Buy
+1,646,260
New +$48.1M 1.8% 18
2021
Q1 		– Sell
-400,000
Closed -$6.63M – 80
2020
Q4 		$6.63M Buy
+400,000
New +$5.2M 0.36% 34

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

EcoR1 Capital's CERE Position: Q3 2022 in Review

EcoR1 Capital sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2022, closing a stake of 1,646,260 shares — an estimated $43.5M sold.

EcoR1 Capital first reported a position in CERE in Q4 2020 and held it in 3 quarters. The position peaked at $57.6M in Q1 2022. 114 funds tracked by Wall St. Rank hold CERE as of Q3 2022.

  • EcoR1 Capital reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • EcoR1 Capital sold 1,646,260 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $43.5M.
  • EcoR1 Capital first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • EcoR1 Capital's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $57.6M in Q1 2022.
  • 114 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on EcoR1 Capital's 13F filing for Q3 2022, filed 14 Nov 2022.